HCV

ViralClear appoints former Celgene exec as chair, dusts off long-shelved hepatitis C drug for Covid-19 trial
MedCity News
Tue, 04/7/20 - 07:27 pm
ViralClear
BioSig Technologies
merimepodib
HCV
clinical trials
COVID-19
Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)
Yahoo/Globe NewsWire
Sat, 11/8/14 - 10:39 am
Achillion
ACH-3102
ACH-3422
HCV
hepatitis C
Encouraging Data from Bristol-Myers
Yahoo/Zacks
Sat, 04/12/14 - 10:20 am
Bristol-Myers Squibb
HCV
hepatitis
hepatitis C
daclatasvir
asunaprevir
Encouraging Results on Gilead's Sovaldi
Yahoo/Zacks
Sat, 04/12/14 - 10:13 am
Gilead Sciences
Sovaldi
HCV
hepatitis
hepatitis C
Boehringer Ingelheim reports positive phase 3 SVR12 results in HCV/HIV co-infected patients treated with faldaprevir
Pharmabiz
Sat, 03/8/14 - 10:49 am
SVR12
Boehringer Ingelheim
HCV
HIV
hepatitis
hepatitis C
BioLineRx to Initiate HCV Study
Yahoo/Zacks
Sat, 03/16/13 - 10:40 am
BioLineRx
HCV
BL-8020
hepatitis C
2012 Roundup -- HCV Treatments
Motley Fool
Sun, 12/30/12 - 12:15 pm
HCV
Vertex Pharmaceuticals
Merck
Gilead Sciences
Abbott Laboratories
hepatitis C
Achillion
Idenix
JNJ
GSK
Idenix Pharmaceuticals' CEO Provides Update on IDX184 Clinical Development Program Conference (Transcript)
Seeking Alpha
Sat, 08/18/12 - 03:39 pm
Idenix
IDX184
HCV
OraSure Technologies Announces Rapid HCV Testing Initiatives for First National Hepatitis Testing Day
Fri, 05/18/12 - 06:21 pm
OraSure
HCV
testing
hepatitis
Watch Achillion Pharmaceutical For Upcoming Phase IIa Data
Forex Pros
Sun, 04/8/12 - 12:44 pm
Achillion
ACH-1625
HCV
hepatitis C
Peregrine Provides Update on HCV Clinical Program
Yahoo
Thu, 12/29/11 - 10:30 pm
HCV
Peregrine Pharmaceuticals
bavituximab
OraSure Technologies Receives CLIA Waiver for OraQuick(R) HCV Rapid Test
Tue, 11/29/11 - 09:05 pm
OraSure
HCV
Presidio Pharmaceuticals, Inc. Announces Clinical Proof-of-Concept Data for its First HCV NS5A Inhibitor, PPI-461, and Initiation of Clinical Testing for its Second-Generation NS5A Inhibitor, PPI-668.
BusinessWire
Sun, 11/6/11 - 12:19 pm
NS5A Inhibitors
PPI-461
PPI-668
HCV
Gilead Amends HCV Combo Study
Yahoo/Zacks.com
Thu, 09/8/11 - 11:11 am
HCV
Gilead
hepatitis C
JNJ
GS 9190
Idera Pharmaceuticals Delays Initiation of Phase 2 Clinical Trial of IMO-2125 in Treatment-Naïve HCV Patients
Yahoo/BusinessWire
Sat, 04/23/11 - 10:47 am
Idera Pharmaceuticals
IMO-2125
HCV
toll-like Receptor (TLR) 9 agonist
Bristol-Myers Presents HCV Data
Yahoo/Zacks
Sat, 04/2/11 - 10:29 am
Bristol-Myers Squibb
HCV
BMS-790052
Positive Data for Vertex HCV Drug
Yahoo/Zacks
Sat, 04/2/11 - 10:23 am
Vertex Pharmaceuticals
VX-222
HCV
Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011
Yahoo/BusinessWire
Sat, 04/2/11 - 10:22 am
Idera Pharmaceuticals
IMO-2125
HCV
Idenix: Not Worth the Wait
Seeking Alpha
Thu, 03/17/11 - 11:01 am
Indenix
hepatitis C
Pharmasset
HCV
Priority Review for Vertex HCV Drug
Zacks
Sat, 01/22/11 - 10:54 am
Vertex Pharmaceuticals
Telaprevir
HCV
hepatitis C

Pages